However, after extracting tumor-specific ORRs from some cancer immunotherapy studies, the correlation of CDKN2A ALT frequency with ORRs did not reach statistical significance (r, 0.2; p = 0.28) in TCGA cohort (Figure S3 D).
← all excerpts
Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment.
1
0.2800
0.2800